• Contact us
  • E-Submission
ABOUT
BROWSE ARTICLES
JOURNAL POLICIES
FOR CONTRIBUTORS

Articles

Page Path

Original Article

The Results of Radiation Therapy as Definitive, Postoperative, and Salvage Therapy for Meningioma

The Ewha Medical Journal 2013;36(2):112-117. Published online: September 26, 2013

Department of Radiation Oncology, Ewha Womans University School of Medicine, Seoul, Korea.

1Department of Radiology, Ewha Womans University School of Medicine, Seoul, Korea.

Corresponding author: Soo Mee Lim. Department of Radiology, Ewha Womans University School of Medicine, 1071 Anyangcheon-ro, Yangcheon-gu, Seoul 158-710, Korea. Tel: 82-2-2650-6022, Fax: 82-2-2650-5301, soomee@ewha.ac.kr
• Received: January 17, 2013   • Accepted: January 30, 2013

Copyright © 2013. Ewha Womans University School of Medicine

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

  • 51 Views
  • 0 Download
prev next
  • Objectives
    Radiation therapy has multiple roles in the treatment of meningioma although surgery remains the primary treatment of choice. In this retrospective study, we report the results of radiation therapy for meningioma as definitive, postoperative or salvage therapies.
  • Methods
    Seventeen patients diagnosed with meningioma were treated with radiation therapy in our institute from May 2000 to October 2009. Radiation therapies were performed as definitive therapies in 8 patients, as postoperative therapies in 5 and as salvage therapies in 4. Nine patients received stereotactic radiosurgery (SRS), 2 patients fractionated stereotactic radiotherapy (FSRT), and 5 patients 3-dimensional conformal radiotherapy (3DCRT). Radiation dose were 12 to 20 Gy for SRS, 36 Gy in 9 fractions for FSRT and 50.4 Gy in 28 fractions for 3DCRT. Follow-up imaging study of computed tomography or magnetic resonance imaging was performed at 6 to 12 months intervals and neurologic exam was performed with an interval less than 6 months.
  • Results
    The median follow-up duration was 38 months (range, 12 to 85 months). Tumor progression after radiation therapy developed in one patient. The reduction of tumor volume measured on follow-up images were more than 20% in 4 patients and minimal change of tumor volume less than 20% were observed in 12 patients. Peritumoral edema developed in 4 patients and disappeared without any treatment. One patient had radiation necrosis.
  • Conclusion
    Our experience is consistent with the current understanding that radiotherapy is as an effective and safe treatment modality for meningiomas when the tumor cannot be resected completely or when recurred after surgery.
  • 1. Tanzler E, Morris CG, Kirwan JM, Amdur RJ, Mendenhall WM. Outcomes of WHO Grade I meningiomas receiving definitive or postoperative radiotherapy. Int J Radiat Oncol Biol Phys 2011;79:508-513.
  • 2. Gondi V, Tome WA, Mehta MP. Fractionated radiotherapy for intracranial meningiomas. J Neurooncol 2010;99:349-356.
  • 3. Henzel M, Gross MW, Hamm K, Surber G, Kleinert G, Failing T, et al. Stereotactic radiotherapy of meningiomas: symptomatology, acute and late toxicity. Strahlenther Onkol 2006;182:382-388.
  • 4. Milker-Zabel S, Zabel A, Schulz-Ertner D, Schlegel W, Wannenmacher M, Debus J. Fractionated stereotactic radiotherapy in patients with benign or atypical intracranial meningioma: long-term experience and prognostic factors. Int J Radiat Oncol Biol Phys 2005;61:809-816.
  • 5. Milker-Zabel S, Zabel-du Bois A, Huber P, Schlegel W, Debus J. Intensity-modulated radiotherapy for complex-shaped meningioma of the skull base: long-term experience of a single institution. Int J Radiat Oncol Biol Phys 2007;68:858-863.
  • 6. Debus J, Wuendrich M, Pirzkall A, Hoess A, Schlegel W, Zuna I, et al. High efficacy of fractionated stereotactic radiotherapy of large base-of-skull meningiomas: long-term results. J Clin Oncol 2001;19:3547-3553.
  • 7. Kondziolka D, Lunsford LD. Radiosurgery of meningiomas. Neurosurg Clin N Am 1992;3:219-230.
  • 8. Minniti G, Amichetti M, Enrici RM. Radiotherapy and radiosurgery for benign skull base meningiomas. Radiat Oncol 2009;4:42.
  • 9. Lo SS, Cho KH, Hall WA, Kossow RJ, Hernandez WL, McCollow KK, et al. Single dose versus fractionated stereotactic radiotherapy for meningiomas. Can J Neurol Sci 2002;29:240-248.
  • 10. Simpson D. The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 1957;20:22-39.
  • 11. Salazar OM. Ensuring local control in meningiomas. Int J Radiat Oncol Biol Phys 1988;15:501-504.
  • 12. DiMeco F, Li KW, Casali C, Ciceri E, Giombini S, Filippini G, et al. Meningiomas invading the superior sagittal sinus: surgical experience in 108 cases. Neurosurgery 2004;55:1263-1272.
  • 13. Dammers R, Hsu SP, Krisht AF. Radioguided improved resection of a cranial base meningioma. Neurosurgery 2009;64:ons84-ons85.
  • 14. Alexiou GA, Gogou P, Markoula S, Kyritsis AP. Management of meningiomas. Clin Neurol Neurosurg 2010;112:177-182.
  • 15. Taylor BW Jr, Marcus RB Jr, Friedman WA, Ballinger WE Jr, Million RR. The meningioma controversy: postoperative radiation therapy. Int J Radiat Oncol Biol Phys 1988;15:299-304.
  • 16. Glaholm J, Bloom HJ, Crow JH. The role of radiotherapy in the management of intracranial meningiomas: the Royal Marsden Hospital experience with 186 patients. Int J Radiat Oncol Biol Phys 1990;18:755-761.
  • 17. Goldsmith BJ, Wara WM, Wilson CB, Larson DA. Postoperative irradiation for subtotally resected meningiomas: a retrospective analysis of 140 patients treated from 1967 to 1990. J Neurosurg 1994;80:195-201.
  • 18. Little KM, Friedman AH, Sampson JH, Wanibuchi M, Fukushima T. Surgical management of petroclival meningiomas: defining resection goals based on risk of neurological morbidity and tumor recurrence rates in 137 patients. Neurosurgery 2005;56:546-559.
  • 19. Condra KS, Buatti JM, Mendenhall WM, Friedman WA, Marcus RB Jr, Rhoton AL. Benign meningiomas: primary treatment selection affects survival. Int J Radiat Oncol Biol Phys 1997;39:427-436.
  • 20. Miralbell R, Linggood RM, de la Monte S, Convery K, Munzenrider JE, Mirimanoff RO. The role of radiotherapy in the treatment of subtotally resected benign meningiomas. J Neurooncol 1992;13:157-164.
  • 21. Mirimanoff RO, Dosoretz DE, Linggood RM, Ojemann RG, Martuza RL. Meningioma: analysis of recurrence and progression following neurosurgical resection. J Neurosurg 1985;62:18-24.
  • 22. Mattozo CA, De Salles AA, Klement IA, Gorgulho A, McArthur D, Ford JM, et al. Stereotactic radiation treatment for recurrent nonbenign meningiomas. J Neurosurg 2007;106:846-854.
  • 23. Rogers L, Mehta M. Role of radiation therapy in treating intracranial meningiomas. Neurosurg Focus 2007;23:E4.
  • 24. Nakamura S, Hiyama H, Arai K, Nakaya K, Sato H, Hayashi M, et al. Gamma Knife radiosurgery for meningiomas: four cases of radiation-induced edema. Stereotact Funct Neurosurg 1996;66:Suppl 1. 142-145.
  • 25. Ganz JC, Schrottner O, Pendl G. Radiation-induced edema after Gamma Knife treatment for meningiomas. Stereotact Funct Neurosurg 1996;66:Suppl 1. 129-133.
  • 26. Ramsey AF BM, Ekstrand K. Edema following gamma knife radiosurgery for intracranial meningiomas. Int J Radiat Oncol Biol Phys 2002;54:146-147.
  • 27. Hudgins WR, Barker JL, Schwartz DE, Nichols TD. Gamma Knife treatment of 100 consecutive meningiomas. Stereotact Funct Neurosurg 1996;66:Suppl 1. 121-128.
  • 28. Al-Mefty O. Clinoidal meningiomas. J Neurosurg 1990;73:840-849.
  • 29. Stafford SL, Pollock BE, Foote RL, Link MJ, Gorman DA, Schomberg PJ, et al. Meningioma radiosurgery: tumor control, outcomes, and complications among 190 consecutive patients. Neurosurgery 2001;49:1029-1037.
  • 30. Paek SH, Kim CY, Kim YY, Park IA, Kim MS, Kim DG, et al. Correlation of clinical and biological parameters with peritumoral edema in meningioma. J Neurooncol 2002;60:235-245.
  • 31. Lawrence YR, Li XA, el Naqa I, Hahn CA, Marks LB, Merchant TE, et al. Radiation dose-volume effects in the brain. Int J Radiat Oncol Biol Phys 2010;76:S20-S27.
Fig. 1
Examples of radiation therapy planning of (A) stereotactic radiosurgery as a salvage therapy for a patient with recurrent meningioma, (B) fractionated stereotactic radiotherapy as a definitive therapy for a patient with unresectable tumor due to a high risk of cranial nerve damage after a surgery and (C) 3-dimensional conformal radiotherapy as a postoperative radiotherapy for a patient with residual tumor after surgical resection.
emj-36-112-g001.jpg
Table 1
Patients characteristics

WHO, World Health Organization.

emj-36-112-i001.jpg
Table 2
Treatment parameters (n=19)

SRS, stereotactic radiosurgery; FSRT, fractionated stereotactic radiotherapy; 3DCRT, 3-dimensional conformal radiotherapy.

emj-36-112-i002.jpg
Table 3
Simpson classification of extent of resection [10]
emj-36-112-i003.jpg

Figure & Data

References

    Citations

    Citations to this article as recorded by  

      Download Citation

      Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

      Format:

      Include:

      The Results of Radiation Therapy as Definitive, Postoperative, and Salvage Therapy for Meningioma
      Ewha Med J. 2013;36(2):112-117.   Published online September 26, 2013
      Download Citation
      Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

      Format:
      • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
      • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
      Include:
      • Citation for the content below
      The Results of Radiation Therapy as Definitive, Postoperative, and Salvage Therapy for Meningioma
      Ewha Med J. 2013;36(2):112-117.   Published online September 26, 2013
      Close

      Figure

      • 0
      The Results of Radiation Therapy as Definitive, Postoperative, and Salvage Therapy for Meningioma
      Image
      Fig. 1 Examples of radiation therapy planning of (A) stereotactic radiosurgery as a salvage therapy for a patient with recurrent meningioma, (B) fractionated stereotactic radiotherapy as a definitive therapy for a patient with unresectable tumor due to a high risk of cranial nerve damage after a surgery and (C) 3-dimensional conformal radiotherapy as a postoperative radiotherapy for a patient with residual tumor after surgical resection.
      The Results of Radiation Therapy as Definitive, Postoperative, and Salvage Therapy for Meningioma

      Patients characteristics

      WHO, World Health Organization.

      Treatment parameters (n=19)

      SRS, stereotactic radiosurgery; FSRT, fractionated stereotactic radiotherapy; 3DCRT, 3-dimensional conformal radiotherapy.

      Simpson classification of extent of resection [10]

      Table 1 Patients characteristics

      WHO, World Health Organization.

      Table 2 Treatment parameters (n=19)

      SRS, stereotactic radiosurgery; FSRT, fractionated stereotactic radiotherapy; 3DCRT, 3-dimensional conformal radiotherapy.

      Table 3 Simpson classification of extent of resection [10]

      TOP